Literature DB >> 14667521

Long-term results of a prospective randomized study comparing two different antireflux techniques in orthotopic bladder substitution.

Yasser Osman1, Hassan Abol-Enein, Adel Nabeeh, Mohamed Gaballah, Mahmoud Bazeed.   

Abstract

PURPOSE: We compared the long-term functional results following two different reflux prevention techniques in orthotopic ileal bladder substitution in a prospective controlled randomized study.
METHODS: The study included 60 patients for whom orthotopic bladder replacement was indicated. The treated patients were prospectively randomized into two groups: group I (30 patients) underwent ileal W neobladder with serous lined extramural tunnel and group II (30 patients) received hemi-Kock pouch with intussuscepted nipple valve. Laboratory evaluation included estimation of serum creatinine while radiological studies included IVU and voiding studies. Urodynamic evaluation was an integral part of our investigation.
RESULTS: Patients and tumor characteristics were comparable between both groups. No operative or postoperative mortality were observed in either. Early complications were encountered in 5 (16.7%) and 4 (13.3%) patients in the two treated groups respectively (p=0.72) and most were treated conservatively. Twenty patients in group I and 19 in group II were evaluable. The mean follow up was 73.9+/-6.6 and 72.9+/-5.6 months in the treated groups respectively. Day and night time continence was comparable between both groups. Ascending studies demonstrated reflux in 3 (7.7%) of the reimplanted units in group I versus 2 (5.3%) in group II (p=0.81); IVU showed uretero-ileal anastomotic strictures in 2 renal units with both the serous lined extramural tunnel (5.1%) and the ileal nipple valve (5.3%) techniques (p=0.98). One patient in group I had pouch stone compared with 5 in group II (p=0.08). Urodynamic characteristics were also comparable in both groups.
CONCLUSION: The study provided evidence that the long-term functional results following serous lined extramural tunnel are as equal as the nipple valve. Furthermore, it spares the use of extra-bowel length, does not need staples and allows retrograde endoscopic procedures.

Entities:  

Mesh:

Year:  2004        PMID: 14667521     DOI: 10.1016/j.eururo.2003.08.006

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  6 in total

1.  Continent cutaneous urinary diversion: long-term follow-up of more than 800 patients with ileocecal reservoirs.

Authors:  Christoph Wiesner; Roland Bonfig; Raimund Stein; Elmar W Gerharz; Sascha Pahernik; Hubertus Riedmiller; Joachim W Thüroff
Journal:  World J Urol       Date:  2006-05-05       Impact factor: 4.226

2.  Radiotherapy in muscle-invasive bladder cancer: the latest research progress and clinical application.

Authors:  Shuo Zhang; Yong-Hua Yu; Yong Zhang; Wei Qu; Jia Li
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

Review 3.  Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy.

Authors:  June D Cody; Ghulam Nabi; Norman Dublin; Samuel McClinton; David E Neal; Robert Pickard; Sze M Yong
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

4.  A novel antireflux technique for orthotopic ileal bladder substitutes-flat-segment technique: preliminary results.

Authors:  Hany Elfayoumy; Ashraf Abou-Elela; Tamer Orban; Ashraf Emran; Mohamed Elghoneimy; Ahmed Morsy
Journal:  ISRN Urol       Date:  2011-09-14

5.  Dipping technique for ureteroileal anastomosis in orthotopic ileal neobladder: 20-year experience in 670 patients-no stenosis with preservation of the upper tract.

Authors:  Mohamed M Wishahi; Hosam Elganzoury; Amr Elkhouly; Ahmed Mehena
Journal:  ISRN Urol       Date:  2013-05-26

6.  Presence of transient hydronephrosis immediately after surgery has a limited influence on renal function 1 year after ileal neobladder construction.

Authors:  Takuma Narita; Shingo Hatakeyama; Takuya Koie; Shogo Hosogoe; Teppei Matsumoto; Osamu Soma; Hayato Yamamoto; Tohru Yoneyama; Yuki Tobisawa; Takahiro Yoneyama; Yasuhiro Hashimoto; Chikara Ohyama
Journal:  BMC Urol       Date:  2017-08-31       Impact factor: 2.264

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.